EDGAR Filing Documents for 0001213900-23-074568

Form 8-K - Current report:

SEC Accession No. 0001213900-23-074568

Filing Date

2023-09-07

Accepted

2023-09-07 08:30:23

Documents

Period of Report

2023-09-04

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea184802-8k_180life.htm iXBRL	8-K	43329
2	SECOND AMENDED AND RESTATED BYLAWS OF 180 LIFE SCIENCES CORP., EFFECTIVE AS OF S	ea184802ex3-1_180life.htm	EX-3.1	137608
3	FORM OF STOCK OPTION AGREEMENT (FIRST AMENDED AND RESTATED 2022 OMNIBUS INCENTIV	ea184802ex10-2_180life.htm	EX-10.2	69257
	Complete submission text file	0001213900-23-074568.txt		523500

Data Files

Seq	Description	Document	Type	Size
4	XBRL SCHEMA FILE	atnf-20230904.xsd	EX-101.SCH	3787
5	XBRL DEFINITION FILE	atnf-20230904_def.xml	EX-101.DEF	26629
6	XBRL LABEL FILE	atnf-20230904_lab.xml	EX-101.LAB	36680
7	XBRL PRESENTATION FILE	atnf-20230904_pre.xml	EX-101.PRE	25253
9	EXTRACTED XBRL INSTANCE DOCUMENT	ea184802-8k_180life_htm.xml	XML	5405

Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306

Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669

180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)